ADT-007
CAS No. 1945941-09-2
ADT-007( —— )
Catalog No. M37557 CAS No. 1945941-09-2
ADT-007 is an orally active and selective pan-RAS inhibitor with potent anticancer activity.ADT-007 blocks GTP activation of RAS and MAPK/AKT signaling by binding to anucleotide RAS.ADT-007 is used in the study of gastrointestinal cancers.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 106 | In Stock |
|
| 5MG | 88 | In Stock |
|
| 10MG | 126 | In Stock |
|
| 25MG | 212 | In Stock |
|
| 50MG | 365 | In Stock |
|
| 100MG | 621 | In Stock |
|
| 200MG | 1014 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameADT-007
-
NoteResearch use only, not for human use.
-
Brief DescriptionADT-007 is an orally active and selective pan-RAS inhibitor with potent anticancer activity.ADT-007 blocks GTP activation of RAS and MAPK/AKT signaling by binding to anucleotide RAS.ADT-007 is used in the study of gastrointestinal cancers.
-
DescriptionADT-007 is an orally active and selective pan-RAS inhibitor with potent anticancer activity.ADT-007 blocks GTP activation of RAS and MAPK/AKT signaling by binding to anucleotide RAS.ADT-007 is used in the study of gastrointestinal cancers.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayMAPK/ERK Signaling
-
TargetRas
-
RecptorRas
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1945941-09-2
-
Formula Weight449.47
-
Molecular FormulaC26H24FNO5
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESC(=C/1\C=2C(C(CC(NCC3=CC=CO3)=O)=C1C)=CC(F)=CC2)\C4=CC(OC)=C(O)C(OC)=C4
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
RAS inhibitor Abd-7
RAS inhibitor Abd-7 is a potent RAS-binding compound (Kd=51 nM) that interacts with RAS in cells.
-
Deltasonamide 1
A novel small molecule inhibitor of PDE6δ/KRas interaction with Kd of 203 pM.
-
J-104871
J-104871 (UNII-6137X5QNJF) is a novel farnesyltransferase (FTase) inhibitor that competitively blocks Ras farnesylation in vivo, inhibits Ras processing in activated H-ras-transformed NIH3T3 cells, and suppresses tumor growth in nude mice transplanted with activated H-ras-transformed NIH3T3 cells.
Cart
sales@molnova.com